Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
8.36
+0.18 (2.20%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Maze Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Maze Therapeutics stock have an average target of 25.67, with a low estimate of 19 and a high estimate of 30. The average target predicts an increase of 207.06% from the current stock price of 8.36.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Maze Therapeutics stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 |
|---|---|---|
| Strong Buy | 1 | 1 |
| Buy | 2 | 2 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
| Total | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +127.27% | Apr 2, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $19 | Strong Buy | Initiates | $19 | +127.27% | Feb 25, 2025 |
| Leerink Partners | Leerink Partners | Buy Initiates $28 | Buy | Initiates | $28 | +234.93% | Feb 25, 2025 |
| JP Morgan | JP Morgan | Buy Initiates $30 | Buy | Initiates | $30 | +258.85% | Feb 25, 2025 |
Financial Forecast
Revenue This Year
3.19M
from 167.50M
Decreased by -98.10%
Revenue Next Year
n/a
from 3.19M
EPS This Year
-2.59
from 1.25
EPS Next Year
-2.70
from -2.59
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 13.1M | n/a | 13.1M |
| Avg | 3.2M | n/a | 3.2M |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -92.2% | - | - |
| Avg | -98.1% | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -2.17 | -2.39 |
| Avg | -2.59 | -2.70 |
| Low | -2.94 | -3.28 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.